Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Peter Lawson's Stock Ratings
Barclays Analyst
Peter Lawson is an analyst at Barclays. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025
Updated: Dec 15, 2025
Overall Average Return
-10.7%
Smart Score
Overall Average Return Percentile
17th
Number of Ratings
148
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 11/04/2025 | SNDX | Buy Now | Syndax Pharmaceuticals | $20.95 | 5.04% | $19 → $22 | Maintains | Overweight | Get Alert | |
| 10/29/2025 | INCY | Buy Now | Incyte | $96.55 | 4.61% | $90 → $101 | Maintains | Overweight | Get Alert | |
| 09/18/2025 | ONC | Buy Now | BeOne Medicines | $302.71 | 27.18% | → $385 | Initiates | → Overweight | Get Alert | |
| 09/04/2025 | IDYA | Buy Now | IDEAYA Biosciences | $33.51 | 19.37% | → $40 | Initiates | → Overweight | Get Alert | |
| 08/14/2025 | SDGR | Buy Now | Schrodinger | $17.92 | 39.51% | → $25 | Initiates | → Overweight | Get Alert | |
| 07/23/2025 | REPL | Buy Now | Replimune Group | $9.79 | -69.36% | $17 → $3 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 07/10/2025 | EXEL | Buy Now | Exelixis | $41.24 | -3.01% | $29 → $40 | Maintains | Equal-Weight | Get Alert | |
| 05/14/2025 | MGNX | Buy Now | Macrogenics | $1.35 | 121.4% | $8 → $3 | Maintains | Overweight | Get Alert | |
| 05/14/2025 | FATE | Buy Now | Fate Therapeutics | $1.12 | 78.57% | $10 → $2 | Maintains | Overweight | Get Alert | |
| 05/14/2025 | ADAP | Buy Now | Adaptimmune Therapeutics | — | — | $1 → $0.46 | Maintains | Underweight | Get Alert | |
| 05/13/2025 | KPTI | Buy Now | Karyopharm Therapeutics | $6.42 | 55.76% | $5 → $10 | Maintains | Overweight | Get Alert | |
| 05/12/2025 | IOVA | Buy Now | Iovance Biotherapeutics | $2.29 | 74.29% | $5 → $4 | Maintains | Overweight | Get Alert | |
| 05/08/2025 | XNCR | Buy Now | Xencor | $16.55 | -63.75% | $22 → $6 | Maintains | Underweight | Get Alert | |
| 05/02/2025 | KURA | Buy Now | Kura Oncology | $10.62 | 3.58% | $32 → $11 | Maintains | Overweight | Get Alert | |
| 05/02/2025 | ARVN | Buy Now | Arvinas | $11.84 | 35.14% | $32 → $16 | Maintains | Overweight | Get Alert | |
| 05/01/2025 | BCYC | Buy Now | Bicycle Therapeutics | $7.40 | 102.7% | $40 → $15 | Maintains | Overweight | Get Alert | |
| 04/28/2025 | SWTX | Buy Now | SpringWorks Therapeutics | — | — | $63 → $47 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 04/23/2025 | RCUS | Buy Now | Arcus Biosciences | $21.68 | -35.42% | $29 → $14 | Maintains | Overweight | Get Alert | |
| 04/14/2025 | IOVA | Buy Now | Iovance Biotherapeutics | $2.29 | 117.86% | $22 → $5 | Maintains | Overweight | Get Alert | |
| 04/02/2025 | BMEA | Buy Now | Biomea Fusion | $1.32 | 126.42% | $11 → $3 | Maintains | Equal-Weight | Get Alert | |
| 03/07/2025 | TCRX | Buy Now | TScan Therapeutics | $0.95 | 215.72% | $14 → $3 | Maintains | Overweight | Get Alert | |
| 02/27/2025 | GERN | Buy Now | Geron | $1.34 | 198.51% | $9 → $4 | Maintains | Overweight | Get Alert | |
| 02/13/2025 | EXEL | Buy Now | Exelixis | $41.24 | -29.68% | $25 → $29 | Maintains | Equal-Weight | Get Alert | |
| 02/03/2025 | ARVN | Buy Now | Arvinas | $11.84 | 170.27% | $48 → $32 | Maintains | Overweight | Get Alert | |
| 10/30/2024 | BMEA | Buy Now | Biomea Fusion | $1.32 | 730.19% | $9 → $11 | Maintains | Equal-Weight | Get Alert | |
| 10/25/2024 | RCUS | Buy Now | Arcus Biosciences | $21.68 | 33.76% | $25 → $29 | Maintains | Overweight | Get Alert | |
| 09/27/2024 | RVMD | Buy Now | Revolution Medicines | $77.92 | -23% | $54 → $60 | Maintains | Overweight | Get Alert | |
| 09/27/2024 | BMEA | Buy Now | Biomea Fusion | $1.32 | 579.25% | $5 → $9 | Maintains | Equal-Weight | Get Alert | |
| 09/10/2024 | RLAY | Buy Now | Relay Therapeutics | $8.54 | 98.95% | $14 → $17 | Maintains | Overweight | Get Alert | |
| 08/15/2024 | SNDX | Buy Now | Syndax Pharmaceuticals | $20.95 | 57.56% | $32 → $33 | Maintains | Overweight | Get Alert | |
| 08/13/2024 | EXAI | Buy Now | Exscientia | — | — | → $5 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 08/09/2024 | IMCR | Buy Now | Immunocore Hldgs | $36.33 | 81.67% | $92 → $66 | Maintains | Overweight | Get Alert | |
| 07/31/2024 | MGNX | Buy Now | Macrogenics | $1.35 | 490.41% | $9 → $8 | Maintains | Overweight | Get Alert | |
| 07/31/2024 | ARVN | Buy Now | Arvinas | $11.84 | 305.41% | $60 → $48 | Maintains | Overweight | Get Alert | |
| 07/29/2024 | BPMC | Buy Now | Blueprint Medicines | — | — | $75 → $105 | Maintains | Equal-Weight | Get Alert | |
| 07/29/2024 | MGNX | Buy Now | Macrogenics | $1.35 | 564.21% | $14 → $9 | Maintains | Overweight | Get Alert | |
| 07/29/2024 | EXAI | Buy Now | Exscientia | — | — | $10 → $9 | Maintains | Overweight | Get Alert | |
| 07/26/2024 | RLAY | Buy Now | Relay Therapeutics | $8.54 | 63.84% | $15 → $14 | Maintains | Overweight | Get Alert | |
| 07/18/2024 | RVMD | Buy Now | Revolution Medicines | $77.92 | -30.7% | $52 → $54 | Maintains | Overweight | Get Alert | |
| 07/15/2024 | NRIX | Buy Now | Nurix Therapeutics | $18.47 | 67.84% | $20 → $31 | Maintains | Overweight | Get Alert | |
| 07/12/2024 | RVMD | Buy Now | Revolution Medicines | $77.92 | -33.26% | → $52 | Initiates | → Overweight | Get Alert | |
| 07/08/2024 | RCUS | Buy Now | Arcus Biosciences | $21.68 | 15.31% | $35 → $25 | Maintains | Overweight | Get Alert | |
| 06/07/2024 | REPL | Buy Now | Replimune Group | $9.79 | 73.65% | $13 → $17 | Maintains | Overweight | Get Alert | |
| 06/07/2024 | BMEA | Buy Now | Biomea Fusion | $1.32 | 277.36% | $30 → $5 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 05/24/2024 | TNGX | Buy Now | Tango Therapeutics | $9.17 | 41.77% | $18 → $13 | Maintains | Overweight | Get Alert | |
| 05/10/2024 | MGNX | Buy Now | Macrogenics | $1.35 | 933.21% | $25 → $14 | Maintains | Overweight | Get Alert | |
| 05/10/2024 | RLAY | Buy Now | Relay Therapeutics | $8.54 | 75.54% | $15 → $15 | Upgrade | Equal-Weight → Overweight | Get Alert | |
| 05/03/2024 | BPMC | Buy Now | Blueprint Medicines | — | — | $70 → $75 | Maintains | Equal-Weight | Get Alert | |
| 04/30/2024 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | $9 → $26 | Upgrade | Underweight → Equal-Weight | Get Alert | |
| 04/11/2024 | EXEL | Buy Now | Exelixis | $41.24 | -39.38% | $25 → $25 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 03/08/2024 | MGNX | Buy Now | Macrogenics | $1.35 | 1745.02% | $23 → $25 | Maintains | Overweight | Get Alert | |
| 03/07/2024 | TCRX | Buy Now | TScan Therapeutics | $0.95 | 847.17% | $7 → $9 | Maintains | Overweight | Get Alert | |
| 02/29/2024 | ARVN | Buy Now | Arvinas | $11.84 | 406.76% | $26 → $60 | Maintains | Overweight | Get Alert | |
| 02/29/2024 | IOVA | Buy Now | Iovance Biotherapeutics | $2.29 | 858.61% | $18 → $22 | Maintains | Overweight | Get Alert | |
| 02/29/2024 | MGNX | Buy Now | Macrogenics | $1.35 | 1597.42% | $12 → $23 | Maintains | Overweight | Get Alert | |
| 02/29/2024 | SWTX | Buy Now | SpringWorks Therapeutics | — | — | $47 → $63 | Maintains | Overweight | Get Alert | |
| 02/27/2024 | FATE | Buy Now | Fate Therapeutics | $1.12 | 792.86% | $6 → $10 | Maintains | Overweight | Get Alert | |
| 02/13/2024 | BPMC | Buy Now | Blueprint Medicines | — | — | $58 → $70 | Maintains | Equal-Weight | Get Alert | |
| 01/30/2024 | EXEL | Buy Now | Exelixis | $41.24 | -39.38% | $24 → $25 | Maintains | Overweight | Get Alert | |
| 01/25/2024 | SWTX | Buy Now | SpringWorks Therapeutics | — | — | $41 → $47 | Maintains | Overweight | Get Alert | |
| 12/06/2023 | REPL | Buy Now | Replimune Group | $9.79 | 32.79% | $50 → $13 | Maintains | Overweight | Get Alert | |
| 12/04/2023 | IMGN | Buy Now | Immunogen | — | — | $27 → $31 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 12/01/2023 | IMGN | Buy Now | Immunogen | — | — | — | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 10/27/2023 | BPMC | Buy Now | Blueprint Medicines | — | — | $46 → $58 | Maintains | Equal-Weight | Get Alert | |
| 10/24/2023 | ARVN | Buy Now | Arvinas | $11.84 | 119.59% | $39 → $26 | Maintains | Overweight | Get Alert | |
| 10/17/2023 | EXAI | Buy Now | Exscientia | — | — | $12 → $10 | Maintains | Overweight | Get Alert | |
| 09/18/2023 | IOVA | Buy Now | Iovance Biotherapeutics | $2.29 | 684.31% | $40 → $18 | Maintains | Overweight | Get Alert | |
| 08/10/2023 | FATE | Buy Now | Fate Therapeutics | $1.12 | 435.71% | $12 → $6 | Maintains | Overweight | Get Alert | |
| 08/10/2023 | ADAP | Buy Now | Adaptimmune Therapeutics | — | — | $2 → $1 | Maintains | Underweight | Get Alert | |
| 08/09/2023 | ARVN | Buy Now | Arvinas | $11.84 | 229.39% | $70 → $39 | Maintains | Overweight | Get Alert | |
| 08/04/2023 | PRLD | Buy Now | Prelude Therapeutics | $1.99 | 151.89% | $7 → $5 | Maintains | Equal-Weight | Get Alert | |
| 08/03/2023 | EXEL | Buy Now | Exelixis | $41.24 | -41.8% | $25 → $24 | Maintains | Overweight | Get Alert | |
| 08/02/2023 | IMGN | Buy Now | Immunogen | — | — | $20 → $27 | Maintains | Overweight | Get Alert | |
| 07/26/2023 | SNDX | Buy Now | Syndax Pharmaceuticals | $20.95 | 62.33% | $31 → $34 | Maintains | Overweight | Get Alert | |
| 06/12/2023 | IMGN | Buy Now | Immunogen | — | — | $9 → $20 | Maintains | Overweight | Get Alert | |
| 05/23/2023 | BPMC | Buy Now | Blueprint Medicines | — | — | $44 → $46 | Maintains | Equal-Weight | Get Alert | |
| 05/12/2023 | BMEA | Buy Now | Biomea Fusion | $1.32 | 3673.58% | → $50 | Initiates | → Overweight | Get Alert | |
| 04/28/2023 | SWTX | Buy Now | SpringWorks Therapeutics | — | — | $55 → $41 | Maintains | Overweight | Get Alert | |
| 04/19/2023 | RLAY | Buy Now | Relay Therapeutics | $8.54 | 75.54% | $23 → $15 | Maintains | Equal-Weight | Get Alert | |
| 03/09/2023 | NRIX | Buy Now | Nurix Therapeutics | $18.47 | 8.28% | → $20 | Initiates | → Overweight | Get Alert | |
| 01/23/2023 | BPMC | Buy Now | Blueprint Medicines | — | — | $50 → $44 | Maintains | Equal-Weight | Get Alert | |
| 01/04/2023 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | $8 → $9 | Maintains | Underweight | Get Alert | |
| 12/21/2022 | RCUS | Buy Now | Arcus Biosciences | $21.68 | 61.44% | $60 → $35 | Maintains | Overweight | Get Alert | |
| 12/12/2022 | BPMC | Buy Now | Blueprint Medicines | — | — | $58 → $53 | Maintains | Equal-Weight | Get Alert | |
| 11/30/2022 | IMCR | Buy Now | Immunocore Hldgs | $36.33 | 120.2% | → $80 | Initiates | → Overweight | Get Alert | |
| 11/23/2022 | ARVN | Buy Now | Arvinas | $11.84 | 491.22% | $90 → $70 | Maintains | Overweight | Get Alert | |
| 11/16/2022 | EXAI | Buy Now | Exscientia | — | — | $40 → $12 | Maintains | Overweight | Get Alert | |
| 11/15/2022 | IMGN | Buy Now | Immunogen | — | — | $8 → $9 | Maintains | Overweight | Get Alert | |
| 11/02/2022 | BPMC | Buy Now | Blueprint Medicines | — | — | $70 → $58 | Maintains | Equal-Weight | Get Alert | |
| 09/30/2022 | RLAY | Buy Now | Relay Therapeutics | $8.54 | 169.16% | → $23 | Initiates | → Equal-Weight | Get Alert | |
| 09/09/2022 | IMGN | Buy Now | Immunogen | — | — | → $8 | Initiates | → Overweight | Get Alert | |
| 09/09/2022 | ARVN | Buy Now | Arvinas | $11.84 | 660.14% | → $90 | Initiates | → Overweight | Get Alert | |
| 08/16/2022 | NEXI | Buy Now | NexImmune | $0.00 | 1999900% | $7 → $2 | Maintains | Overweight | Get Alert | |
| 08/09/2022 | MGNX | Buy Now | Macrogenics | $1.35 | 490.41% | $18 → $8 | Maintains | Overweight | Get Alert | |
| 08/05/2022 | KPTI | Buy Now | Karyopharm Therapeutics | $6.42 | 24.61% | $14 → $8 | Maintains | Overweight | Get Alert | |
| 07/28/2022 | BCYC | Buy Now | Bicycle Therapeutics | $7.40 | 305.41% | → $30 | Initiates | → Overweight | Get Alert | |
| 07/07/2022 | CTMX | Buy Now | CytomX Therapeutics | $4.13 | -15.36% | $7 → $3.5 | Maintains | Overweight | Get Alert | |
| 04/01/2022 | NEXI | Buy Now | NexImmune | $0.00 | 6999900% | $4 → $7 | Maintains | Overweight | Get Alert | |
| 02/28/2022 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | $11 → $6 | Downgrade | Equal-Weight → Underweight | Get Alert | |
| 02/28/2022 | PRLD | Buy Now | Prelude Therapeutics | $1.99 | 504.53% | $20 → $12 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 01/18/2022 | CTMX | Buy Now | CytomX Therapeutics | $4.13 | 69.29% | → $7 | Upgrade | Underweight → Overweight | Get Alert | |
| 11/19/2021 | RCUS | Buy Now | Arcus Biosciences | $21.68 | 176.75% | $48 → $60 | Maintains | Overweight | Get Alert | |
| 11/17/2021 | PRLD | Buy Now | Prelude Therapeutics | $1.99 | 907.56% | $33 → $20 | Maintains | Overweight | Get Alert | |
| 11/09/2021 | RCUS | Buy Now | Arcus Biosciences | $21.68 | 121.4% | $45 → $48 | Maintains | Overweight | Get Alert | |
| 11/08/2021 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | $50 → $11 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 10/08/2021 | PRLD | Buy Now | Prelude Therapeutics | $1.99 | 1562.47% | $80 → $33 | Maintains | Overweight | Get Alert | |
| 08/06/2021 | ILMN | Buy Now | Illumina | $131.26 | 178.07% | $355 → $365 | Maintains | Underweight | Get Alert | |
| 05/28/2021 | CTMX | Buy Now | CytomX Therapeutics | $4.13 | 69.29% | $9 → $7 | Downgrade | Equal-Weight → Underweight | Get Alert | |
| 05/28/2021 | ADAP | Buy Now | Adaptimmune Therapeutics | — | — | → $4 | Initiates | → Underweight | Get Alert | |
| 05/19/2021 | IOVA | Buy Now | Iovance Biotherapeutics | $2.29 | 1642.92% | $60 → $40 | Maintains | Overweight | Get Alert | |
| 03/12/2021 | MGNX | Buy Now | Macrogenics | $1.35 | 2852.03% | $14 → $40 | Upgrade | Underweight → Overweight | Get Alert | |
| 02/18/2021 | BPMC | Buy Now | Blueprint Medicines | — | — | $90 → $95 | Maintains | Equal-Weight | Get Alert | |
| 02/10/2021 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | $85 → $70 | Maintains | Overweight | Get Alert | |
| 10/22/2020 | AGIO | Buy Now | Agios Pharmaceuticals | $26.27 | 75.1% | → $46 | Upgrade | Equal-Weight → Overweight | Get Alert | |
| 10/06/2020 | IOVA | Buy Now | Iovance Biotherapeutics | $2.29 | 1468.63% | $45 → $36 | Maintains | Overweight | Get Alert | |
| 05/22/2020 | SNDX | Buy Now | Syndax Pharmaceuticals | $20.95 | 9.81% | $25 → $23 | Maintains | Overweight | Get Alert | |
| 05/05/2020 | BPMC | Buy Now | Blueprint Medicines | — | — | → $59 | Initiates | → Equal-Weight | Get Alert | |
| 05/05/2020 | IMMU | Buy Now | Immunomedics | — | — | → $40 | Initiates | → Overweight | Get Alert | |
| 05/05/2020 | REPL | Buy Now | Replimune Group | $9.79 | 114.5% | → $21 | Initiates | → Overweight | Get Alert | |
| 03/04/2020 | NKTR | Buy Now | Nektar Therapeutics | $50.55 | -40.66% | → $30 | Initiates | → Overweight | Get Alert | |
| 03/04/2020 | EPZM | Buy Now | Epizyme | — | — | → $33 | Initiates | → Overweight | Get Alert | |
| 03/04/2020 | XNCR | Buy Now | Xencor | $16.55 | 69.18% | → $28 | Initiates | → Underweight | Get Alert | |
| 03/04/2020 | IOVA | Buy Now | Iovance Biotherapeutics | $2.29 | 1860.78% | → $45 | Initiates | → Overweight | Get Alert | |
| 03/04/2020 | AGIO | Buy Now | Agios Pharmaceuticals | $26.27 | 90.33% | → $50 | Initiates | → Equal-Weight | Get Alert | |
| 03/04/2020 | MGNX | Buy Now | Macrogenics | $1.35 | 490.41% | → $8 | Initiates | → Underweight | Get Alert | |
| 03/04/2020 | SNDX | Buy Now | Syndax Pharmaceuticals | $20.95 | -28.38% | → $15 | Initiates | → Overweight | Get Alert | |
| 03/04/2020 | EXEL | Buy Now | Exelixis | $41.24 | -36.95% | → $26 | Initiates | → Overweight | Get Alert | |
| 03/04/2020 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | → $70 | Initiates | → Overweight | Get Alert | |
| 03/04/2020 | RCUS | Buy Now | Arcus Biosciences | $21.68 | 10.7% | → $24 | Initiates | → Overweight | Get Alert | |
| 03/04/2020 | FATE | Buy Now | Fate Therapeutics | $1.12 | 3471.43% | → $40 | Initiates | → Overweight | Get Alert | |
| 03/04/2020 | KPTI | Buy Now | Karyopharm Therapeutics | $6.42 | 367.29% | → $30 | Initiates | → Overweight | Get Alert | |
| 03/11/2019 | CTMX | Buy Now | CytomX Therapeutics | $4.13 | — | — | Initiates | → Overweight | Get Alert | |
| 12/04/2018 | TSRO | Buy Now | Tesaro | — | — | $65 → $75 | Downgrade | Buy → Hold | Get Alert | |
| 05/31/2018 | CYAD | Buy Now | Celyad Oncology | — | — | → $49 | Initiates | → Buy | Get Alert | |
| 04/23/2018 | UMRX | Buy Now | Unum Therapeutics | — | — | → $21 | Initiates | → Buy | Get Alert | |
| 04/09/2018 | NLNK | Buy Now | NewLink Genetics | — | — | $19 → $5 | Downgrade | Buy → Hold | Get Alert | |
| 01/23/2018 | CRSP | Buy Now | CRISPR Therapeutics | $55.38 | -18.74% | $16 → $45 | Upgrade | Hold → Buy | Get Alert | |
| 01/23/2018 | EDIT | Buy Now | Editas Medicine | $2.50 | 1700% | $17 → $45 | Upgrade | Hold → Buy | Get Alert | |
| 01/23/2018 | JUNO | Buy Now | Juno Therapeutics | — | — | — | Downgrade | Buy → Hold | Get Alert | |
| 07/14/2017 | AFMD | Buy Now | Affimed | — | — | → $7 | Initiates | → Buy | Get Alert | |
| 07/14/2017 | EDIT | Buy Now | Editas Medicine | $2.50 | 580% | → $17 | Initiates | → Hold | Get Alert | |
| 07/14/2017 | CRSP | Buy Now | CRISPR Therapeutics | $55.38 | -71.11% | → $16 | Initiates | → Hold | Get Alert | |
| 03/30/2017 | NLNK | Buy Now | NewLink Genetics | — | — | → $30 | Upgrade | Hold → Buy | Get Alert | |
| 11/25/2016 | JUNO | Buy Now | Juno Therapeutics | — | — | $48 → $25 | Downgrade | Buy → Hold | Get Alert | |
| 05/11/2016 | NLNK | Buy Now | NewLink Genetics | — | — | — | Downgrade | Buy → Neutral | Get Alert | |
| 03/01/2016 | TSRO | Buy Now | Tesaro | — | — | — | Initiates | → Buy | Get Alert | |
| 01/29/2016 | JUNO | Buy Now | Juno Therapeutics | — | — | → $50 | Initiates | → Buy | Get Alert | |
| 12/22/2015 | NLNK | Buy Now | NewLink Genetics | — | — | → $59 | Initiates | → Buy | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved